Shane Olwill

Shane Olwill

Company: Pieris Pharmaceuticals

Job title: Senior Vice President & Chief Development Officer


Advantages & Disadvantages of Different Molecule Types for Inhaled Drug Delivery 3:30 pm

• Panel Discussion and Q&ARead more

day: Track A, PM

Moderated Discussion: Analyzing Biologics, Small Molecules & Antibodies for the Treatment of ILD to Determine Which One is Most Easily Inhaled, Nebulized & Absorbed by the Alveoli 2:00 pm

Discussing and debating the benefits and drawbacks of biologics, small molecules and antibodies for inhaled drug delivery Understanding what characteristics give rise to more easily inhaled molecules Exploring challenges associated with alveolar uptake of inhaled therapies in interstitial lung disease and understanding how to overcome themRead more

day: Track A, AM

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.